このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

S&S Healthcare Holding マネジメント

マネジメント基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Chih-Ming Yeh

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	no data
CEOの所有権	1.7%
経営陣の平均在職期間	データなし
取締役会の平均在任期間	データなし

経営陣の近況

Recent updates

Here's Why S&S Healthcare Holding (GTSM:4198) Can Afford Some Debt

Apr 22

Is S&S Healthcare Holding (GTSM:4198) A Risky Investment?

Jan 07

CEO（最高経営責任者

Chih-Ming Yeh

no data

在職期間

Chih-Ming Yeh is Chief Executive Officer of S&S Healthcare Holding Ltd.

S&S Healthcare Holding マネジメント

マネジメント基準チェック /04

主要情報

経営陣の近況

S&S Healthcare Holding Ltd., Annual General Meeting, Jun 20, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Investor sentiment improves as stock rises 23%

First quarter 2024 earnings released: NT$0.79 loss per share (vs NT$0.60 loss in 1Q 2023)

S&S Healthcare Holding Ltd., Annual General Meeting, Jun 20, 2024

Investor sentiment improves as stock rises 20%

Full year 2023 earnings released: EPS: NT$4.49 (vs NT$3.77 loss in FY 2022)

New minor risk - Share price stability

Second quarter 2023 earnings released: NT$1.06 loss per share (vs NT$1.10 loss in 2Q 2022)

Full year 2022 earnings released: NT$3.77 loss per share (vs NT$6.52 loss in FY 2021)

Less than half of directors are independent

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Third quarter 2021 earnings released: NT$0.37 loss per share (vs NT$0.36 loss in 3Q 2020)

Second quarter 2021 earnings released: NT$0.24 loss per share (vs NT$0.55 loss in 2Q 2020)

Here's Why S&S Healthcare Holding (GTSM:4198) Can Afford Some Debt

Full year 2020 earnings released: NT$1.87 loss per share (vs NT$3.58 loss in FY 2019)

Is S&S Healthcare Holding (GTSM:4198) A Risky Investment?

New 90-day low: NT$7.16

Third quarter 2020 earnings released: NT$0.36 loss per share

New 90-day high: NT$14.50

New 90-day high - NT$7.35

CEO（最高経営責任者

在職期間

S&S Healthcare Holding マネジメント

マネジメント 基準チェック /04

主要情報

経営陣の近況

S&S Healthcare Holding Ltd., Annual General Meeting, Jun 20, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Investor sentiment improves as stock rises 23%

First quarter 2024 earnings released: NT$0.79 loss per share (vs NT$0.60 loss in 1Q 2023)

S&S Healthcare Holding Ltd., Annual General Meeting, Jun 20, 2024

Investor sentiment improves as stock rises 20%

Full year 2023 earnings released: EPS: NT$4.49 (vs NT$3.77 loss in FY 2022)

New minor risk - Share price stability

Second quarter 2023 earnings released: NT$1.06 loss per share (vs NT$1.10 loss in 2Q 2022)

Full year 2022 earnings released: NT$3.77 loss per share (vs NT$6.52 loss in FY 2021)

Less than half of directors are independent

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Third quarter 2021 earnings released: NT$0.37 loss per share (vs NT$0.36 loss in 3Q 2020)

Second quarter 2021 earnings released: NT$0.24 loss per share (vs NT$0.55 loss in 2Q 2020)

Here's Why S&S Healthcare Holding (GTSM:4198) Can Afford Some Debt

Full year 2020 earnings released: NT$1.87 loss per share (vs NT$3.58 loss in FY 2019)

Is S&S Healthcare Holding (GTSM:4198) A Risky Investment?

New 90-day low: NT$7.16

Third quarter 2020 earnings released: NT$0.36 loss per share

New 90-day high: NT$14.50

New 90-day high - NT$7.35

CEO（最高経営責任者

在職期間

マネジメント基準チェック /04